AAV-ie Enables Safe and Efficient Gene Transfer to Inner Ear Cells.

Fangzhi Tan,Cenfeng Chu,Jieyu Qi,Wenyan Li,Dan You,Ke Li,Xin Chen,Weidong Zhao,Cheng,Xiaoyi Liu,Yunbo Qiao,Bing Su,Shuijin He,Chao Zhong,Huawei Li,Renjie Chai,Guisheng Zhong

DOI: https://doi.org/10.1038/s41467-019-11687-8

IF: 16.6

2019-01-01

Nature Communications

Abstract:Hearing loss is the most common sensory disorder. While gene therapy has emerged as a promising treatment of inherited diseases like hearing loss, it is dependent on the identification of gene delivery vectors. Adeno-associated virus (AAV) vector-mediated gene therapy has been approved in the US for treating a rare inherited eye disease but no safe and efficient vectors have been identified that can target the diverse types of inner ear cells. Here, we identify an AAV variant, AAV-inner ear (AAV-ie), for gene delivery in mouse inner ear. Our results show that AAV-ie transduces the cochlear supporting cells (SCs) with high efficiency, representing a vast improvement over conventional AAV serotypes. Furthermore, after AAV-ie-mediated transfer of the Atoh1 gene, we find that many SCs trans-differentiated into new HCs. Our results suggest that AAV-ie is a useful tool for the cochlear gene therapy and for investigating the mechanism of HC regeneration.